Silence Therapeutics (SLN) Total Current Liabilities (2019 - 2025)
Historic Total Current Liabilities for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $17.4 million.
- Silence Therapeutics' Total Current Liabilities rose 17908.51% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year increase of 17908.51%. This contributed to the annual value of $16.8 million for FY2024, which is 2468.66% down from last year.
- Latest data reveals that Silence Therapeutics reported Total Current Liabilities of $17.4 million as of Q3 2025, which was up 17908.51% from $14.8 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Total Current Liabilities registered a high of $25.7 million during Q4 2022, and its lowest value of -$30.6 million during Q3 2022.
- Over the past 5 years, Silence Therapeutics' median Total Current Liabilities value was -$21.3 million (recorded in 2023), while the average stood at -$9.0 million.
- As far as peak fluctuations go, Silence Therapeutics' Total Current Liabilities plummeted by 18568.81% in 2023, and later soared by 20712.63% in 2025.
- Over the past 5 years, Silence Therapeutics' Total Current Liabilities (Quarter) stood at $20.4 million in 2021, then increased by 25.89% to $25.7 million in 2022, then crashed by 185.69% to -$22.1 million in 2023, then surged by 176.28% to $16.8 million in 2024, then increased by 3.31% to $17.4 million in 2025.
- Its last three reported values are $17.4 million in Q3 2025, $14.8 million for Q2 2025, and $19.3 million during Q1 2025.